Finanznachrichten

Galderma Announces Triple Approval of New State-of-the-Art Restylane Syringe in the EU, the U.S., and Canada, Reaffirming the Company's Position at the Forefront of Injectable ...

Regulatory authorities in the European Union (EU), the United States (U.S.), and Canada have approved a new state-of-the-art Restylane syringe for use with a range of Restylane NASHA lidocaine ...
Morningstar

Merz Aesthetics® Introduces New BELOTERO® Syringe Offering Greater Precision, Comfort and Ease of Use

Redesigned syringe seamlessly blends innovation and functionality, setting a new standard for precision and ease in the injection experience. Merz Aesthetics, the world’s largest dedicated medical ...
Business Wire

Merz Aesthetics Celebrates A New Milestone: Ten Million Syringes of Radiesse ® Shipped Worldwide

“As we reflect on this milestone, we are proud of the fact that, Radiesse has proven to provide aesthetic practitioners with a unique treatment that they can administer confidently, while supporting ...
Business Insider

Allergan Aesthetics Celebrates 100 Million Syringes of JUVÉDERM®

JUVÉDERM ® Collection of Fillers Continues Position as the World's Number One Chosen Dermal Filler Collection IRVINE, Calif., Sept. 7, 2022 /PRNewswire/ -- Today, Allergan Aesthetics, an AbbVie ...
Yahoo Finance

Galderma Announces Triple Approval of New State-of-the-Art Restylane® Syringe in the EU, the U.S., and Canada, Reaffirming the Company’s Position at the Forefront of ...

Developed in collaboration with aesthetic practitioners, its innovative ergonomic design features a cushioned finger grip and thumb rest, to improve practitioner experience through better injection ...
The Bakersfield Californian

Merz Aesthetics® Introduces New BELOTERO® Syringe Offering Greater Precision, Comfort and Ease of Use

Merz Aesthetics, the world’s largest dedicated medical aesthetics business, announced today the launch of a new syringe for its category-leading hyaluronic acid (HA) brand BELOTERO ®. The new syringe ...
Morningstar

Galderma Announces Triple Approval of New State-of-the-Art Restylane® Syringe in the EU, the U.S., and Canada, Reaffirming the Company’s Position at the Forefront of ...

Galderma (SIX: GALD), today announced that regulatory authorities in the EU, the U.S., and Canada have approved a new state-of-the-art syringe for use with its NASHA® lidocaine range of Restylane ...